Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-25-002084

CHIEF ACCOUNTING OFFICER bought 20,000 shares at $1.42 ($28,400)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lerner Neil CHIEF ACCOUNTING OFFICER 2025-04-07 Purchase +20,000 $1.42 $28,400 320,000 D
Open-market purchases · 20,000 sh · avg $1.42 · $28,400
Loading xslF345X05/ownership.xml…